To register for MyChart, our patient communication and information system, please choose from the following options:
If you have an activation code from your enrollment letter/provider:
Don't have a code?
How-to guides and tips for MyChart Users
Get an immediate, self-serve price estimate through MyChart - no account or login required!
Community offers board-certified hepatobiliary surgery specialists with more than 20 years of experience treating liver, gallbladder, bile duct and pancreatic cancers and related diseases.
Meet the Hepatobiliary Cancer Providers
To make an appointment for hepatobiliary cancer treatment or other needs, please call our office at 317-621-3970 or call Community's oncology scheduling specialists at 317-621-2627.
The hepatobiliary (HPB) system refers to the liver, gall bladder and bile ducts, and how they work together to make bile. Cancers can affect all the organs in this system. When discussing cancers, the pancreas is often grouped with hepatobiliary cancers because of its connection to the bile ducts and role in the digestive process.
The liver is the largest organ in the body, located below the right lung. Its function is to remove toxins and waste from the body and produce bile to help with digestion. More than 41,000 new cases of primary liver cancer will be diagnosed in the U.S. in 2023, although it is much more common in other parts of the world where hepatitis B infections are common (e.g., sub-Saharan Africa). Primary liver cancer (that has not spread from other parts of the body) is much more common in men than women and in people with chronic liver disease, such as cirrhosis or hepatitis B or C. Obesity, high alcohol intake and inherited metabolic diseases are also risk factors. Treatment options for liver cancer may include surgery to remove the tumor, tumor ablation, tumor embolization, radiation therapy, targeted therapy and chemotherapy.
Gallbladder cancer is a relatively rare cancer. According to the American Cancer Society, about 12,220 new cases will be diagnosed in 2023. The gallbladder is a small, pear-shaped organ that sits below the liver, behind the ribs. Bile produced by the liver is stored in the gallbladder and released as needed. The gallbladder is not an essential organ; people can live healthy lives if the gallbladder is removed.
Gallbladder cancer typically strikes older people (aged 70 and above). It is more common among Mexican Americans, southwestern Native Americans, and people from certain South American countries, particularly Chile. Risk factors include gallstones and inflammation, obesity, family history, polyps and others. Treatment options for gallbladder cancer may include surgery, radiation therapy and chemotherapy.
Bile duct cancer is a rare cancer; about 8,000 people in the United States develop bile duct cancer each year. It typically occurs in older people over age 65. Bile duct cancer is much more common in Asia and the Middle East. Risk factors include diseases of the liver or bile ducts, including chronic inflammation (ulcerative colitis), bile duct stones, choledochal cysts, smoking, diabetes and others. Treatment for bile duct cancer may include surgery, radiation therapy and chemotherapy.
Pancreatic cancer is the fourth leading cause of cancer death in the U.S. In 2023, more than 64,000 people will be diagnosed with it. The cancer starts in the tissues of the pancreas, an organ that lies behind the lower part of the stomach. Cancer in the pancreas spreads fast and symptoms are often not apparent until the cancer is at an advanced stage, which is why it is a leading cause of cancer deaths. Exocrine pancreatic cancer is the most common type; endocrine pancreatic cancer is less common. Risk factors for pancreatic cancer include smoking, obesity, age 55 and older, African American race, pancreatitis, genetic factors, family history and diabetes. Treatment options for pancreatic cancer may include surgery, ablation, radiation therapy and chemotherapy.
